Publications by authors named "M M Huberman"

Article Synopsis
  • Lacosamide is an FDA-approved antiepileptic drug used for treating partial-onset seizures, but it has been associated with potential cardiac side effects, such as PR prolongation and AV block.
  • A case study details a three-week-old girl who developed second-degree AV heart block and cardiac arrest after starting lacosamide for seizures, despite having no prior cardiac issues.
  • The study suggests that the safety of lacosamide in neonates requires further evaluation, particularly in light of this first reported instance of serious cardiac complications linked to its use.
View Article and Find Full Text PDF

Plasma cell myeloma (PCM) is defined as a clonal disease of terminally differentiated plasma cells that secrete immunoglobulin. The biologic underpinnings of IgA-type multiple myeloma's (IgAMM) aggressive nature, including its increased morbidity and mortality, have not been elucidated. We describe the clinical, phenotypic, and cytogenetic characteristics of IgA-MM.

View Article and Find Full Text PDF

Purpose: Coronavirus disease 2019 (COVID-19) pandemic has been an unprecedented public health crisis. As hospitals took measures to increase their capacity to manage COVID-19 patients, plastic surgeons have also had to modify their routine to continue serving their vital role within the hospital environment. In an effort to reduce exposure to COVID-19 and conserve hospital resources, many plastic surgery programs drastically modified call schedules, restructured inpatient teams, triaged operative cases, and expanded telemedicine encounters.

View Article and Find Full Text PDF

A young female in her early 20s with a history of systemic lupus erythematosus presented to the emergency department due to 4 days of progressive bilateral extremity weakness and numbness. The patient reported flu-like symptoms that had spontaneously recovered 2 weeks prior to her presentation. She was 10 weeks pregnant at presentation.

View Article and Find Full Text PDF

Irisin, a newly discovered protein hormone that is secreted in response to low frequency whole body vibration (LFV), could be a promising post-stroke rehabilitation therapy for patients who are frail and cannot comply with regular rehabilitation therapy. Irisin is generated from a membrane-bound precursor protein fibronectin type III domain-containing protein 5 (FNDC5). Aside from being highly expressed in muscle, FNDC5 is highly expressed in the brain.

View Article and Find Full Text PDF